Loading stock data…
INNV
$7.69+0.32 (+4.34%)
After Hours$7.69+0.00 (+0.00%)· Last close Jun 9
InnovAge Holding Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
InnovAge Holding Corp. in the Healthcare sector is trading at $7.69 with a market capitalization of $961M. Wall Street consensus targets $7.00 (1 analysts), implying a -9.0% move over the next 12 months. The stock is currently 28% below its 52-week high of $10.69, remaining 20.0% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -9.0% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$7.69
Potential Downside
0%
Whystock Fair Value$7.69
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the El...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$961.01M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.49
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-5.07%
Volume
Today's trading volume
512,421
Recent News
Why InnovAge Holding (INNV) Is Down 9.0% After Raising 2026 Revenue Guidance Amid Wider Loss
In May 2026, InnovAge Holding Corp. reported third-quarter results showing sales of US$251.5 million and revenue of US$251.94 million, alongside a net loss of US$29.46 million and a basic and diluted loss per share from continuing operations of US$0.22, all compared with the same quarter a year earlier. Despite the wider loss, management raised full-year 2026 revenue guidance to a range of US$950 million to US$975 million, signaling stronger confidence in top-line performance even as...
InnovAge Holding Corp. Q3 2026 Earnings Call Summary
Moby summary of InnovAge Holding Corp.'s Q3 2026 earnings call
InnovAge Q3 Earnings Call Highlights
InnovAge (NASDAQ:INNV) reported fiscal third-quarter 2026 results that management said reflected “stronger operating execution” and the benefits of investments made to strengthen its platform. The company, which operates Programs of All-Inclusive Care for the Elderly (PACE) centers, posted approxima
InnovAge Holding Corp. (INNV) Reports Q3 Loss, Beats Revenue Estimates
InnovAge (INNV) delivered earnings and revenue surprises of -488.01% and +7.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality?
InnovAge heads into fiscal Q3 earnings with strong growth momentum and margin gains, but seasonal cost pressures and fading Medicaid tailwinds may temper near-term upside.